What is associated with chronic low- to medium-dose inhaled corticosteroid use in children?

Chronic low- to medium-dose inhaled corticosteroid use in children is often associated with a significantly favorable profile, particularly regarding symptom management and the reduction of asthma exacerbations. While there is concern about potential long-term adverse effects, several studies suggest that when inhaled corticosteroids are used appropriately at low to medium doses, particularly in a controlled manner, their benefits in managing asthma symptoms can outweigh the risks.

In children, inhaled corticosteroids are essential for maintaining asthma control as they reduce inflammation in the airways, thus improving lung function and growth in asthmatic children compared to those who do not receive medication. The goal is to minimize symptoms and improve the quality of life, which correlates with enhancing overall lung growth as well.

It's important to note that while there's a recognition of possible risks associated with long-term use of inhaled corticosteroids, current evidence emphasizes that these risks are significantly lower when the medication is administered at low to medium doses under medical supervision. This underlines the focus on symptom management without substantial long-term adverse effects occurring from such usage.